Search results for "Comment"

showing 10 items of 283 documents

Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis.

1999

Neutrophil-borne heparin-binding protein (HBP) is a multifunctional protein involved in the progression of inflammation. HBP is stored in neutrophil granules and released upon stimulation of the cells in proximity to endothelial cells. HBP affects endothelial cells in multiple ways; however, the molecular and cellular mechanisms underlying the interaction of HBP with these cells are unknown. Affinity isolation and enzymatic degradation demonstrated that HBP released from human neutrophils binds to endothelial cell-surface proteoglycans, such as syndecans and glypican. Flow cytometry indicated that a significant fraction of proteoglycan-bound HBP is taken up by the endothelial cells, and we …

Umbilical VeinsEndotheliumCell SurvivalNeutrophilsmedia_common.quotation_subjectmedicine.medical_treatmentInflammationApoptosisBiologyFibroblast growth factorLeukotriene B4ArticleChromatography AffinityFlow cytometryParacrine CommunicationLeukocytesmedicineAnimalsHumansInternalizationCells Culturedmedia_commonInflammationmedicine.diagnostic_testHeparinMonocyteGrowth factorBiological TransportGeneral MedicineBlood ProteinsMolecular biologyRecombinant ProteinsMitochondriaN-Formylmethionine Leucyl-PhenylalanineKineticsmedicine.anatomical_structureApoptosisCommentaryTetradecanoylphorbol AcetateProteoglycansEndothelium Vascularmedicine.symptomCarrier ProteinsAntimicrobial Cationic PeptidesThe Journal of clinical investigation
researchProduct

Vitamin C as a promoter of γδ T cells

2020

none

Vitamin CChemistrybusiness.industryT-LymphocytesT cellCommentImmunologyReceptors Antigen T-Cell gamma-deltaAscorbic AcidAscorbic acidMolecular biologyInfectious DiseasesText miningmedicine.anatomical_structureAntigenCorrespondencemedicineImmunology and AllergyLymphocytesPromoter Regions GeneticReceptorbusinessBiomarkersCellular & Molecular Immunology
researchProduct

Il libro I dell’Epitome proverbiorum Didymi et Tarrhaei di Zenobio: introduzione, edizione critica e commento filologico (prov. 1-30)

Zenobio Epitome Proverbi Edizione CommentoSettore L-FIL-LET/05 - Filologia Classica
researchProduct

Les sources informelles du droit du commerce international produites par la CNUDCI

2008

International audience

[SHS.DROIT]Humanities and Social Sciences/Lawcommentaire critique[SHS.DROIT] Humanities and Social Sciences/LawProjet de la Commission des Nations Unies sur le droit du commerce international (CNUDCI)sur les mesures provisoires dans l'arbitrage commercial internationalComputingMilieux_MISCELLANEOUS[ SHS.DROIT ] Humanities and Social Sciences/Law
researchProduct

Du bon usage des voyages ; l'intégration du témoignage des Modernes dans les commentaires philologiques sur la manne des Anciens

2007

[SHS.DROIT]Humanities and Social Sciences/Lawcommentaires philologiques[SHS.DROIT] Humanities and Social Sciences/Lawtémoignagebon usage des voyages[ SHS.DROIT ] Humanities and Social Sciences/LawModernes
researchProduct

Canto XVI

2016

[SHS.LITT] Humanities and Social Sciences/LiteratureinterprétationRoland furieuxcommentaireArioste
researchProduct

Defining gut mycobiota for wild animals: a need for caution in assigning authentic resident fungal taxa

2021

Animal gut mycobiota, the community of fungi that reside within the gastrointestinal tract, make an important contribution to host health. Accordingly, there is an emerging interest to quantify the gut mycobiota of wild animals. However, many studies of wild animal gut mycobiota do not distinguish between the fungi that likely can reside within animal gastrointestinal tracts from the fungal taxa that are non-residents, such as macrofungi, lichens or plant symbionts/pathogens that can be ingested as part of the host’s diet. Confounding the non-resident and resident gut fungi may obscure attempts to identify processes associated with the authentic, resident gut mycobiota per se. To redress th…

amplicon sequencinghost-microbe interactionsekvensointisuolistomikrobistoMicrobiotaVeterinary medicinedigestive oral and skin physiologyfungiCommunity analysisintestinal fungicommunity analysismicrofungiMicrobiologyQR1-502Intestinal fungimycobiomeHost-microbe interactionvillieläimetSF600-1100CommentarymicrobiotaMicrofungisienetMycobiomeAmplicon sequencingAnimal Microbiome
researchProduct

Mapping routine measles vaccination in low- and middle-income countries

2021

The safe, highly effective measles vaccine has been recommended globally since 1974, yet in 2017 there were more than 17 million cases of measles and 83,400 deaths in children under 5 years old, and more than 99% of both occurred in low- and middle-income countries (LMICs)1–4. Globally comparable, annual, local estimates of routine first-dose measles-containing vaccine (MCV1) coverage are critical for understanding geographically precise immunity patterns, progress towards the targets of the Global Vaccine Action Plan (GVAP), and high-risk areas amid disruptions to vaccination programmes caused by coronavirus disease 2019 (COVID-19)5–8. Here we generated annual estimates of routine childhoo…

and promotion of well-beingVacunación MasivaInternationalityDisease preventionchildren under 5 years oldGeographic MappingRural Healthmedicine.disease_causeCross-reactivity0302 clinical medicineRA0421Vaccination Refusal030212 general & internal medicineChildimmunity patternsPediatric0303 health sciencesPublic healthMultidisciplinarybiologyVaccinationUncertaintyIMMUNIZATION3142 Public health care science environmental and occupational healthCOVERAGE3. Good healthTIME3.4 VaccinesChild PreschoolInfectious diseasesA990 Medicine and Dentistry not elsewhere classifiedAntibodyEngineering sciences. TechnologyAFRICAGeneral Science & TechnologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Disease prevention ; COVID-19 ; Public health ; Infectious diseases610 Medicine & healthGlobal Vaccine Action Plan (GVAP)Local Burden of Disease Vaccine Coverage CollaboratorsArticleVaccine Related03 medical and health sciencesmeasles vaccineMeasels ; Vaccination ; Low- and middle-income countries ; Local burden of disease ; Public healthClinical ResearchmedicineHumansHealthcare DisparitiesPreschoolPROGRESS030304 developmental biologybusiness.industryMORTALITYDeveloped CountriesPreventionCommentVacunaciónUrban HealthCOVID-19Prevention of disease and conditionsVirologyCoronavirusGood Health and Well BeingCobertura de Vacunaciónbiology.proteinImmunizationbusinessMeasles
researchProduct

Phage therapy

2013

Bacteriophage therapy, the use of viruses that infect bacteria as antimicrobials, has been championed as a promising alternative to conventional antibiotics. Although in the laboratory bacterial resistance against phages arises rapidly, resistance so far has been an only minor problem for the effectiveness of phage therapy. Resistance to antibiotics, however, has become a major issue after decades of extensive use. Should we expect similar problems after long-term use of phages as antimicrobials? Like antibiotics, phages are often noted to be drivers of bacterial evolution. Should we expect phage-treated pathogens to develop a general resistance to phages over time, a resistance against whi…

antibiotic resistancephage resistancevirusesevolutionViews and Commentariesecologyphage-therapyBacteriophage
researchProduct

Ancient Medicine in the Galenic Corpus: The Story of a Concealment

2021

The paper proposes, starting from some certain or probable allusions (in part. a passage in Galen's Commentary on 'Epidemics' 2, only extant in Arabic translation), but also from some striking omissions ('Ancient medicine' is not mentioned in the history of hygiene that Galen traces out in the central chapters of Thrasybulus), to reconstruct the history of this significant ‘concealment’. This will also be done in the light of the numerous passages in the corpus in which Galen advocates, constantly linking it to Hippocrates, the ideal of medicine that is ‘physiologica’.

arabic translation of Galen's Hippocratic Commentaries.GalenHippocrates 'Ancient medicine'Settore L-FIL-LET/02 - Lingua E Letteratura Greca
researchProduct